Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ)
301130.SZ Stock Price Chart
Explore Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd interactive price chart. Choose custom timeframes to analyze 301130.SZ price movements and trends.
301130.SZ Company Profile
Discover essential business fundamentals and corporate details for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Chemicals
IPO Date
23 Feb 2022
Employees
269.00
Website
https://xidianyy.comCEO
Jun Zhang
Description
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sale of pharmaceutical products. The company offers drugs for the treatment of anemia, mental disorders, cardiovascular diseases, tumors, etc., as well as traditional Chinese medicines and raw materials. It provides drugs in the form of oral solids and freeze-dried powder injections. The company was founded in 1993 and is based in Panshi, China.
301130.SZ Financial Timeline
Browse a chronological timeline of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2025
EPS came in at ¥0.22 , while revenue for the quarter reached ¥76.09M .
Dividend declared on 29 May 2025
A dividend of ¥0.26 per share was announced, adjusted to ¥0.26. The dividend was paid on 29 May 2025.
Earnings released on 23 May 2025
EPS came in at ¥0.08 , while revenue for the quarter reached ¥63.82M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.11 , while revenue for the quarter reached ¥52.22M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.13 , while revenue for the quarter reached ¥63.61M .
Earnings released on 29 Jun 2024
EPS came in at ¥0.14 , while revenue for the quarter reached ¥60.86M .
Dividend declared on 12 Jun 2024
A dividend of ¥0.26 per share was announced, adjusted to ¥0.26. The dividend was paid on 12 Jun 2024.
Earnings released on 24 May 2024
EPS came in at ¥0.17 , while revenue for the quarter reached ¥65.20M .
Earnings released on 23 Feb 2024
EPS came in at ¥0.14 , while revenue for the quarter reached ¥56.41M .
Earnings released on 31 Dec 2023
EPS came in at ¥0.11 , while revenue for the quarter reached ¥53.61M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.26 , while revenue for the quarter reached ¥58.65M .
Dividend declared on 12 Jun 2023
A dividend of ¥0.16 per share was announced, adjusted to ¥0.16. The dividend was paid on 12 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.12 , while revenue for the quarter reached ¥55.44M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.11 , while revenue for the quarter reached ¥71.25M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.14 , while revenue for the quarter reached ¥67.59M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.16 , while revenue for the quarter reached ¥63.52M .
Dividend declared on 30 Jun 2022
A dividend of ¥0.13 per share was announced, adjusted to ¥0.13. The dividend was paid on 30 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at ¥0.12 , while revenue for the quarter reached ¥53.11M .
Earnings released on 31 Dec 2021
EPS came in at ¥0.22 , while revenue for the quarter reached ¥78.87M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.14 , while revenue for the quarter reached ¥70.68M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.21 , while revenue for the quarter reached ¥73.88M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.17 , while revenue for the quarter reached ¥62.23M .
Earnings released on 31 Dec 2020
EPS came in at ¥0.20 , while revenue for the quarter reached ¥82.66M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.20 , while revenue for the quarter reached ¥81.24M .
301130.SZ Stock Performance
Access detailed 301130.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.